tized patients but reduced phagocytosis in monocytes from propofolanesthetized patients. In vitro, propofol stimulated phagocytosis but reversed pressure-induced phagocytosis in THP-1 macrophages and monocytes from healthy volunteers. The GABAA receptor antagonists picrotoxin and SR-95531 did not affect basal THP-1 phagocytosis or prevent pressure-stimulated phagocytosis. However, picrotoxin and SR-95531 negated the inhibitory effect of pressure in propofol-treated cells without altering propofol-induced phagocytosis. Phosphorylation of the adaptor protein p130cas was inversely related to phagocytosis: it was inhibited by pressure or propofol but increased by pressure ϩ propofol compared with propofol alone. Reduction of p130cas by small interfering RNA in THP-1 macrophages increased basal phagocytosis and prevented pressure and propofol effects. In conclusion, propofol may alter macrophage responses to pressure via the GABAA receptor and p130cas, whereas pressure also acts via p130cas but independently of GABAA receptors. p130cas may be an important target for modulation of macrophage function in anesthetized patients.
anesthesia; mechanotransduction; monocyte SURGICAL STRESS AND ANESTHESIA can exert profound effects on immune function (39, 59) . The immunosuppressive effects of surgical and anesthetic intervention include impaired T cell proliferation (39) , decreased natural killer cell cytotoxicity (43) , and altered phagocytic cell function (5, 23) . After surgery, the imbalance between pro-and anti-inflammatory cytokines released by monocytes and macrophages may promote dysfunction of innate cellular immunity and increased susceptibility to infection (35, 59) . Phagocytosis by alveolar macrophages or neutrophils is decreased during and after major surgery (28) .
Macrophages play a particular role in host defense and wound repair (31) . Although monocytes and macrophages are recruited from peripheral blood to wound sites over time, tissue macrophages are already present within the tissue at the wound site, and phagocytosis of cell debris and contaminated bacteria at the wound site by macrophages is essential for wound repair and prevention of infection (21, 22) . This process begins early after injury, although it may persist for days thereafter. Depletion of macrophages, but not neutrophils, from wound sites impairs wound debridement and delays wound healing (31) , whereas enhancement of macrophage phagocytosis by administration of heat shock protein 70 accelerates wound healing in mice (29) .
The intravenous anesthetic agent propofol is commonly used to induce and maintain anesthesia during surgical or other invasive procedures and to sedate critically ill patients (33, 61) . Propofol is also known to alter the functions of immunocompetent cells, such as neutrophils, monocytes, and macrophages (10, 11, 36) . Propofol decreases proinflammatory cytokine production and inducible nitric oxide synthase expression in LPS-stimulated mouse macrophage Raw 264.7 cells (10, 11) and increases bacterial accumulation in lung and liver after venous infusion compared with the effects of saline infusion (26) . Propofol binds to the ␤ 2 -subunit of the GABA A receptor (4, 16) , which regulates Cl Ϫ channels (32) . Some investigators have reported that ion channels, such as those regulating Cl Ϫ and Ca 2ϩ fluxes, might affect phagocytosis by macrophages and microglia (15, 24) . The effects of propofol on macrophage phagocytic activity, therefore, may be potentially important in surgical wound healing.
Inflammation or edema in closed compartments may increase tissue pressure by 5-80 mmHg, and at surgical wound sites, pressure edema may also increase tissue pressures (3, 56) . Negative-pressure therapy has been shown to promote wound healing and reduce hospital stay in postsurgical patients (12, 47) . Recent reports suggest that mechanical stimuli, such as extracellular pressure and repetitive strain, may alter other aspects of macrophage functions (25, 34) . Pressure (40 -130 mmHg) increases monocyte migration in a dose-dependent manner and enhances scavenger receptor expression in macrophages (44, 55) ; increased pressure (40 -90 mmHg) has been shown to increase aggregated IgG uptake in mouse macrophage J774.16 cells (34) , and extracellular pressure modulates the release of proinflammatory cytokines from human monocytic cells (50) . Mechanical strain augments matrix metalloproteinase (MMP)-1 and MMP-3, but not MMP-9, expression in PMA-treated human monocytes or macrophages (63) . Therefore, it may be important to understand the effect of extracellular pressure on macrophage functions.
We previously reported that exposure to constant low extracellular pressure (20 mmHg) enhances phagocytosis by human peripheral monocytes and PMA-differentiated THP-1 macrophages through activation of p38 and the phosphatidylinositol 3-kinase (PI3K)-Akt-p70S6k pathway and by inhibition of focal adhesion kinase (FAK) and ERK (51) (52) (53) . This is important because interstitial tissue pressure may increase at wound sites after surgery. We hypothesized that propofol infusion might affect macrophage phagocytosis and its responsiveness to extracellular pressure. We therefore examined the effect of propofol on macrophage phagocytosis under ambient and increased pressure and sought to characterize the potential role of the GABA A receptor and intracellular signaling events in mediating the propofol effects that we observed.
METHODS
Antibodies and chemicals. Antibodies against total and phosphorylated Akt, total Akt, phosphorylated ERK, total and phosphorylated p38, and phosphorylated p130cas were purchased from Cell Signaling Technology (Beverly, MA). Antibodies against total ERK and total p130cas were obtained from Upstate (Charlottesville, VA) and BD Transduction Laboratories (San Jose, CA), respectively. Fluorescence-labeled latex beads (2.0 m) were obtained from Polysciences (Warrington, PA). The GABAA receptor antagonist picrotoxin and SR-95531 hydrobromide were purchased from EMD Chemicals (La Jolla, CA) and Tocris Bioscience (Elisville, MO), respectively.
Cells and cell cultures. The human monocytic cell line THP-1 was obtained from the American Type Culture Collection (Rockville, MD) and maintained in RPMI 1640 medium (GIBCO, Grand Island, NY) supplemented with 10% FBS (Sigma, St. Louis, MO), L-glutamine (200 mM), and 2-mercaptoethanol (5 ϫ 10 Ϫ5 M; Sigma). THP-1 cells (5 ϫ 10 5 cells per 35-mm dish) were differentiated by stimulation with PMA (50 ng/ml final concentration) for 3 days to yield a macrophage-like phenotype.
Peripheral venous blood was obtained from consenting healthy volunteers and consenting patients undergoing general anesthesia at 30 min after induction of anesthesia by a protocol approved by Wayne State University School of Medicine and the John D. Dingell Veterans Affairs Medical Center. Peripheral blood mononuclear cells were isolated from heparinized venous blood by Ficoll-Hypaque densitygradient sedimentation as described previously (51) . Peripheral blood mononuclear cells were suspended at a density of 5 ϫ 10 6 /ml in RPMI 1640 medium supplemented with penicillin G (100 U/ml), 2 mM L-glutamine, and 5% fresh unheated human serum. One 100-l droplet of cell suspension was plated in each well of a LabTek chamber, which was incubated for 60 min at 37°C. Nonadherent cells were washed off, and the monocyte monolayers were used for phagocytosis assay.
Assay for phagocytosis. Macrophage phagocytosis increases in a time-dependent manner and reaches a plateau at 1-2 h after exposure to foreign materials. We therefore incubated monocytes or macrophages with latex beads under ambient or increased pressure for 2 h to assess their phagocytosis. Fluorescence-labeled latex beads (2.0 m) were opsonized with 10% unheated FBS for 60 min at 37°C before the experiments. PMA-differentiated THP-1 cells (1 ϫ 10 6 ) in 1 ml of tissue culture medium supplemented with 10% FBS in a 35-mm petri dish were mixed with opsonized latex beads at a multiplicity ratio of 1:5 and then incubated for 2 h at 37°C. One set of dishes was placed in a calibrated pressure box described previously (51, 53) . The pressure inside the box was set at 20 mmHg, and the pressure box was placed inside an incubator at 37°C and monitored every 15 min. The second set of dishes was placed inside the same incubator but under ambient pressure conditions. After 2 h, macrophage monolayers were washed vigorously with PBS to remove extracellular beads, fixed with methanol for 10 min, and then counterstained with methylene blue. The number of intracellular latex particles was determined by counting fluorescent beads within cells under a fluorescence microscope. Data are expressed as percent phagocytosis, calculated as the total number of cells with at least one bead relative to the total number of cells counted.
Western blotting. THP-1 macrophages were incubated under ambient or increased pressure (20 mmHg) for 30 min, rinsed once with cold PBS, and lysed with lysis buffer B [50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10 mM Na pyrophosphate, 50 mM NaF, 10% glycerol, 1% Triton X-100, and 1% dioxycholic acid (pH 7.6) supplemented with 1 mM PMSF, 10 g/ml leupeptin, and 10 g/ml aprotinin]. Protein concentrations in cell lysates were measured using the bicinchoninic acid protein assay reagent (Pierce, Rockford, IL). Equal amounts of protein were loaded in each lane. Cell lysates were resolved under reducing conditions by 10% SDS-PAGE and then transferred to nitrocellulose membranes. The membranes were blocked with 5% BSA in Tris-buffered saline with 0.1% Tween 20 and incubated with antibodies against activated or total forms of protein overnight at 4°C, washed three times with 0.1% Tween 20 ϩ Tris-buffered saline, and then incubated again for 60 min with 2,000:1 peroxidase-conjugated anti-rabbit IgG. The membrane-bound peroxidase activity was detected using ECL Plus Western Blotting Detection kits (Amersham, Arlington Heights, IL). Chemiluminescent images were captured and analyzed using a Kodak Digital Science Image Station 440CF. All blots were studied within the linear range of exposure.
Transfection of small interfering RNA. For inhibition of p130cas protein expression, THP-1 cells were transfected with small interfering RNA (siRNA). The siRNA duplex targeted to human p130cas, 5Ј-dTGGTCGACAGTGGTGTGTATdT/dTCCAGCTGTCACCACACATdT-5Ј, directed toward the mRNA target 5Ј-GGTCGACAGT-GGTGTGTAT-3Ј was designed using Deqor, a web-based tool for the design and quality control of siRNAs and synthesized by Dharmacon (Lafayette, CO). Nontargeted siRNA duplex (NT1) used as a control was purchased from Dharmacon. THP-1 cells (4 ϫ 10 5 per 60-mm petri dish) were stimulated with PMA (50 ng/ml) for 2 days before transfection. Transfection of duplex siRNAs was performed using Oligofectamine (GIBCO, Gaithersburg, MD) according to the manufacturer's protocol. At 24 -48 h after transfection, cells were used for Western analysis and assays of phagocytosis. Transfection efficacy, measured by transfection of Cy3-conjugated siRNA targeted to luciferase (Upstate, Charlottesville, VA), was 90 -97% (53) .
Statistical analysis. The significance of differences between groups was calculated by Student's t-test or paired t-test as appropriate. Bonferroni's or Sidak's correction was applied for multiple comparisons where appropriate. The desired level of statistical significance was set a priori at 95% confidence.
RESULTS
In vivo exposure to propofol alters ex vivo macrophage phagocytosis and its response to increased pressure. We previously reported that increased extracellular pressure (20 mmHg above ambient pressure) stimulates serum-opsonized latex bead uptake by primary isolated monocytes from healthy volunteers as well as PMA-differentiated human monocytic THP-1 cells (THP-1 macrophages) (51) (52) (53) . Several reports suggest that anesthetic agents and surgical stress may affect phagocytic cell function (5, 23, 28) and that tissue pressure may be increased within surgical wounds or at surgical sites postoperatively (56) . Therefore, in a pilot study, we compared the effects of increased extracellular pressure on the phagocytosis of primary monocytes isolated from the peripheral venous blood of normal healthy volunteers and from the peripheral venous blood of four randomly chosen patients receiving anesthesia. Exposure to pressure increased phagocytosis in monocytes from healthy volunteers (22.9 Ϯ 3.3 vs. 31.8 Ϯ 4.7%, n ϭ 8, P Ͻ 0.005; Fig. 1A ), consistent with our previous observations (51, 52) . However, pressure failed to increase phagocytosis in monocytes isolated from surgical patients receiving anesthesia (Fig. 1B) . Further analysis revealed that two patients had received anesthetics including propofol, a commonly used intravenous anesthetic agent, and two patients had been anesthetized without propofol. Indeed, the monocytes from the two patients non-propofol-anesthetized patients displayed increased phagocytosis in response to pressure, similar to monocytes from healthy volunteers, whereas the monocytes from the two propofol-anesthetized patients exhibited decreased phagocytosis in response to extracellular pressure (Fig.   1B ). To confirm this observation, we sampled monocytes from an additional seven propofol-anesthetized patients and three non-propofol-anesthetized patients and obtained similar results (Fig. 1C ). Pooling these samples for statistical analysis revealed that pressure statistically significantly increased phagocytosis in monocytes from non-propofol-anesthetized patients (36.54 Ϯ 3.54 vs. 49.63 Ϯ 3.27%, n ϭ 5, P Ͻ 0.02), just as we observed in the healthy volunteers. However, in monocytes obtained from propofol-anesthetized patients, pressure not only did not increase, but it actually significantly decreased, phagocytosis (44.25 Ϯ 4.58 vs. 31.39 Ϯ 4.03%, n ϭ 9, P Ͻ 0.001).
Similar effects of in vitro and in vivo propofol exposure on macrophages. Next, we examined whether propofol modulates macrophage phagocytosis in vitro in primary isolated peripheral monocytes obtained from healthy volunteers and in THP-1 macrophages. Initially, to define the optimal condition for in vitro propofol treatment, we tested the exposure time to propofol and the propofol dose using THP-1 macrophages, in which we previously demonstrated a response to pressure similar to that of primary monocytes (51, 52) . THP-1 macrophages were pretreated for 15 min-4 h with 10 g/ml propofol or the equivalent amount of Intralipid, the vehicle in which propofol is delivered clinically ( Fig. 2A ). Pretreatment with Intralipid or propofol increased basal phagocytosis in a time-dependent manner that reached a plateau at 2 h. Pressure increased phagocytosis in Intralipid-treated cells at all time points tested. In propofol-treated cells, inhibition of phagocytosis by pressure was observed after 30 min, and this effect lasted Ն4 h after in vitro propofol treatment. Our observations in primary monocytes are also consistent with the idea that the propofol effect may last for Ն4 h, because the blood monocyte isolation and preparation procedure takes Ն3-4 h after the blood is drawn, and we observed persistent changes 4 h later in propofol-anesthetized patients.
Next, THP-1 macrophages were pretreated with various doses of propofol (2.5-20 g/ml) or Intralipid for 30 min (Fig.  2B) . At lower concentrations, Intralipid did not affect basal phagocytosis and pressure increased phagocytosis, whereas propofol increased basal phagocytosis and pressure reversed the propofol-stimulated phagocytosis. Optimal propofol and pressure effects were observed at 10 g/ml propofol. A higher Primary human peripheral monocytes were isolated from 7 propofol-anesthetized patients and 3 non-propofol-anesthetized patients. Monocytes were incubated with serum-opsonized fluorescence-labeled latex beads (5 beads/cell) under ambient pressure or increased pressure for 2 h, washed with PBS, and then fixed. Pressure increased phagocytosis in monocytes from non-propofolanesthetized patients, but pressure decreased phagocytosis in monocytes from propofol-infused patients.
dose of Intralipid (a vehicle control equivalent to 20 g/ml propofol) tended to also increase basal phagocytosis, but pressure exerted a further stimulatory effect in cells treated with this concentration of Intralipid. In contrast, in cells treated with 20 g/ml propofol, phagocytosis did not increase with pressure, although whether phagocytosis was actually inhibited was difficult to discern in the presence of the increased baseline.
Picrotoxin also cancelled the pressure effect in propofoltreated monocytes, as well as in propofol-treated THP-1 macrophages. Furthermore, our previous studies (51, 52) demonstrated a similar response of THP-1 macrophages and primary isolated monocytes from healthy volunteers to extracellular pressure with regard to increased phagocytosis, and this pressure-stimulated phagocytosis is mediated similarly by activation of the p38 MAPK and PI3K-Akt pathways in primary monocytes and THP-1 macrophages. On the basis of these results, we used THP-1 macrophages as a model system for further analysis.
In subsequent studies, we pretreated monocytes or THP-1 macrophages with 10 g/ml propofol for 30 min, because 10 g/ml is similar to pharmacologically relevant concentrations during anesthesia (8, 14) and the propofol effect was not observed until Ն30 min after propofol exposure. Pressure significantly increased phagocytosis in cells treated with the Intralipid vehicle control (Fig. 3, A and B) , similar to cells evaluated without experimental pharmacological treatment (Fig. 1A) . Pretreatment with propofol significantly increased basal phagocytosis by primary monocytes (39.70 Ϯ 10.03 vs. 50.47 Ϯ 7.70%, n ϭ 3, P Ͻ 0.05) and THP-1 macrophages (17.82 Ϯ 1.44 vs. 22.82 Ϯ 1.07%, n ϭ 10, P Ͻ 0.001), but phagocytosis by primary monocytes (Fig. 3A) and THP-1 macrophages (Fig. 3B ) treated with propofol was significantly reduced by pressure [39.37 Ϯ 7.67% (n ϭ 3, P Ͻ 0.05) and 18.42 Ϯ 0.71% (n ϭ 10, P Ͻ 0.01), respectively].
GABA A receptor may mediate the effect of propofol on pressure-stimulated phagocytosis but does not contribute to modulation of phagocytosis by propofol under ambient pressure. Propofol binds to the GABA A receptor ␤ 2 -subunit and exerts at least some of its actions via the GABA A receptor (16) . Gillette and Dacheux (19) demonstrated that GABA A receptors are activated by pressure in rabbit retina, and pressure application might contribute to activation of the GABA A receptor. We used the GABA A receptor antagonists picrotoxin (a noncompetitive antagonist) and SR-95531 (a competitive antagonist) to examine whether the GABA A receptor mediates the propofol effect on macrophage phagocytosis. Primary isolated monocytes (Fig. 4A) or THP-1 macrophages (Fig. 4B) were preincubated with 2 M picrotoxin or THP-1 macrophages were incubated with 2 M SR-95531 (Fig. 4C) for 30 min before pretreatment with Intralipid or propofol. Neither picrotoxin nor SR-95531 affected basal phagocytosis at ambient pressure or stimulation of phagocytosis by propofol at ambient pressure. However, picrotoxin (Fig. 4, A and B) and SR-95531 (Fig. 4C ) each prevented the inhibition of phagocytosis by pressure in propofol-treated cells.
To further validate these results, THP-1 macrophages were similarly pretreated with the competitive antagonist SR-95531 for 30 min, and SR-95531 was removed before stimulation with Intralipid or propofol or pressure. As shown in Fig. 4D , phagocytosis in THP-1 macrophages pretreated with SR-95531, which was then removed, resembled that observed in untreated intact THP-1 macrophages. Phagocytosis was increased by pressure or propofol alone, and pressure inhibited phagocytosis in propofol-stimulated cells from which SR-95531 had been removed. These data suggest that propofol may stimulate phagocytosis at ambient pressure independently of the GABA A receptor but that the GABA A receptor may mediate reversal of the pressure effect on phagocytosis by propofol. Propofol does not act via the signal pathways previously reported to mediate the pressure effect on phagocytosis. Previous studies demonstrated that decreasing FAK and ERK activation and increasing the activation of p38 and the PI3K-Akt-p70S6k pathway contribute to the stimulation of macrophage phagocytosis by extracellular pressure (51) (52) (53) . We therefore examined the effect of propofol on these signals. Propofol did not affect FAK, p38, or Akt phosphorylation under ambient or increased pressure conditions (data not shown). In contrast, pretreatment with propofol significantly increased ERK phosphorylation compared with cells treated with Intralipid at ambient pressures (P Ͻ 0.05, n ϭ 8), whereas exposure to pressure inhibited ERK phosphorylation in Intralipid-and propofol-treated THP-1 macrophages (P Ͻ 0.02, n ϭ 8; Fig. 5 ). Since our previous study demonstrated that inhibition of ERK activation by pressure is accompanied by increased THP-1 macrophage phagocytosis by pressure (52), it seems unlikely that activation of ERK at ambient pressure contributes to increased phagocytosis at ambient pressure by propofol or that modulation of ERK contributes to the propofol effect in pressure-stimulated macrophages. These data suggest that FAK, p38, ERK, and Akt may not mediate the modulation of macrophage phagocytosis by propofol under ambient or increased pressure conditions. p130cas may mediate propofol-and pressure-stimulated phagocytosis. p130cas (a Crk-associated substrate) is a docking protein involved in regulation of the actin cytoskeleton and cell migration (1, 20, 45, 48) . Some studies suggest that p130cas may be involved in bacterial or apoptotic cell phagocytosis by macrophages (6, 18, 49) . We therefore examined whether p130cas phosphorylation might contribute to the stimulation of phagocytosis by extracellular pressure and the reversal of this effect by propofol. Exposure to increased pressure or pretreatment with propofol significantly inhibited p130cas phosphorylation in THP-1 macrophages. However, the combination of propofol and pressure increased p130cas phosphorylation compared with propofol alone (Fig. 6A) . The inverse parallels between phagocytosis and p130cas phosphorylation in all four conditions raised the possibility that modulation of p130cas phosphorylation by pressure or propofol might contribute to the effects of these stimuli on macrophage phagocytosis.
To further evaluate the role of p130cas in mediating pressure-stimulated macrophage phagocytosis and the effect of propofol on macrophage phagocytosis, p130cas protein expression was inhibited by transfection with specific siRNA targeted to p130cas. Transfection with p130cas siRNA reduced total p130cas protein by 60.1 Ϯ 5.6% (n ϭ 5, P Ͻ 0.001) compared with cells transfected with NT1 control siRNA (Fig. 6B ). Cells transfected with NT1 or p130cas siRNA were preincubated with the vehicle control Intralipid or propofol before the phagocytosis assay. In NT1-transfected THP-1 macrophages treated with Intralipid, pressure significantly increased phagocytosis (n ϭ 9, P Ͻ 0.01), and basal phagocytosis was also significantly increased in cells transfected with p130cas siRNA compared with cells transfected with NT1 (n ϭ 9, P Ͻ 0.05, by Student's t-test with Bonferroni's or Sidak's correction), but pressure did not further increase phagocytosis in cells transfected with p130cas siRNA (Fig. 6C) . Propofol increased basal phagocytosis and pressure reversed phagocytosis in propofoltreated cells transfected with NT1 siRNA, similar to the effects of these stimuli in control THP-1 cells and normal primary human monocytes. Phagocytosis was significantly increased by p130cas reduction in THP-1 cells treated with Intralipid at ambient pressure. However, phagocytosis in cells transfected with p130cas siRNA was neither increased by propofol nor reversed by pressure (Fig. 6C) . Surveys of the distribution of cells with different numbers of beads in these experiments demonstrated that the number of bioavailable beads was not a limiting factor (not shown). These data suggest that pressure and/or propofol may increase macrophage phagocytosis by inhibiting p130cas phosphorylation.
Since a specific pharmacological inhibitor for p130cas was not available, we reduced p130cas with specifically targeted siRNA. Because basal phosphorylation was increased by p130cas reduction but there was no further increase with the combination of propofol and pressure, we might have concluded that p130cas is required for the effects of propofol and pressure on phagocytosis or that the reduction in p130cas maximally stimulated phagocytosis by an unrelated pathway so that no further modulation of phagocytosis by propofol or pressure was possible. To address this issue, we examined the effects of stimulation of phagocytosis by LPS (5 g/ml) in THP-1 macrophages in which p130cas had been reduced by transfection with p130cas siRNA. Despite similar p130cas reduction, LPS stimulated phagocytosis (data not shown), suggesting that the cells had not been maximally stimulated by cas reduction and supporting the alternate hypothesis that cas mediates the effects of propofol and pressure on phagocytosis. Modulation of p130cas phosphorylation by pressure and propofol appears independent of the GABA A receptor. Our results suggest that the effect of propofol on macrophage phagocytosis may be mediated through GABA A receptor activation and reduction of p130cas phosphorylation. To examine whether inhibition of p130cas phosphorylation by propofol requires GABA A receptor activation, we evaluated the effects of Intralipid, propofol, and pressure on p130cas phosphorylation in THP-1 macrophages treated with the GABA A receptor antagonist picrotoxin. As described above, exposure to pressure or pretreatment with propofol significantly inhibited p130cas phosphorylation, and pressure increased p130cas phosphorylation in propofol-treated cells. Picrotoxin also inhibited p130cas phosphorylation in Intralipid (vehicle)-treated THP-1 macrophages at ambient pressure, but pressure did not affect p130cas phosphorylation in Intralipid-treated THP-1 macrophages (Fig. 7, left) . In propofol-treated cells, there was no further inhibition of p130cas phosphorylation by picrotoxin, and exposure to pressure increased p130cas phosphorylation in picrotoxintreated cells (Fig. 7, right) . These data suggest that propofol increases basal and reverses pressure-stimulated macrophage phagocytosis through inhibition of p130cas phosphorylation independently of the GABA A receptor activation that is also separately required for propofol to reverse the pressure effect.
DISCUSSION
Mononuclear phagocytes, such as monocytes and macrophages, are the first line of host defense against infection and inflammation and play pivotal roles in wound repair (2, 31) . Recruitment of macrophages into wound sites is a critical event for the early stage of wound healing (21, 22) . Increasing the recruitment of monocytes or macrophages accelerates wound healing (22, 60) . Inhibition of macrophage phagocytosis with antimacrophage serum also slows wound healing (31), whereas administration of heat shock protein 70, which stimulates macrophage phagocytosis (60), accelerates wound healing (29) . These reports suggest that macrophage phagocytosis is essential for normal wound healing.
Although circulating monocytes are recruited to the surgical wound, tissue macrophages existing skin and organs targeted by the surgical procedure might be exposed to propofol during anesthesia and surgery (21, 31, 62) . Leibovich and Ross (31) reported that elimination of local macrophages at the wound site impairs the wound-healing process, and impaired macrophage phagocytic function also leads to a defect in wound healing (54) . Furthermore, macrophages might be activated at the wound site, where a large amount of the intracellular content is released into the extracellular space (29) , and these macrophages produce cytokines, growth factors, and chemokines, which promote further recruitment of immune cells (7, 41) . These tissue macrophages may play important roles in wound healing immediately after surgery.
Propofol is most widely used to induce and maintain anesthesia during surgical or other invasive procedures, for sedation in critically ill patients, and for improved outcomes by protecting neurological tissue against ischemia in neurosurgical settings (33, 61) . Propofol has been proposed to decrease lipid peroxidation and activate the immune system (13). Conversely, propofol has also been reported to inhibit immune cell functions, such as LPS-induced cytokine release and the oxidative stress response (10) . Propofol also attenuates Kupffer cell activation and LPS-induced hepatocellular damage (57, 58) . The effect of propofol on phagocytosis has not been clear. Some investigators have reported that propofol inhibits phagocytosis in neutrophils and macrophages in vitro (11, 30) , and others described no effect of propofol on human leukocyte phagocytosis (42) .
The present study investigated the effect of the commonly used anesthetic agent propofol on macrophage phagocytosis. Increased extracellular pressure stimulated phagocytosis in monocytes isolated from healthy volunteers, as reported previously (51, 52) , and similarly stimulated phagocytosis in monocytes from non-propofol-anesthetized surgical patients. In contrast, exposure to increased extracellular pressure reduced phagocytosis in monocytes from propofol-anesthetized surgical patients. Furthermore, ex vivo pretreatment with propofol increased basal phagocytosis and reversed the effects of pressure on phagocytosis in monocytes isolated from healthy volunteers and non-propofol-anesthetized patients. Mechanistic studies have demonstrated that exposure to pressure or propofol increases phagocytosis by inhibiting p130cas phosphorylation and that the reversal of pressure-stimulated macrophage phagocytosis by propofol is mediated by GABA A receptors. Moreover, downregulation of p130cas phosphorylation contributed to increased macrophage phagocytosis by extracellular pressure or propofol treatment, and the stimulation of p130cas phosphorylation by pressure might mediate reversal of phagocytosis in propofol-treated cells. In our initial study (Fig. 1) , we evaluated the effect of extracellular pressure on phagocytosis in monocytes obtained from patients who received general anesthesia with or without propofol. Pressure increased phagocytosis in monocytes from non-propofol-anesthetized patients, similar to the effects of pressure on monocytes from healthy volunteers, but pressure did not have this effect in propofol-anesthetized patients. The effects of propofol are sufficient to explain our findings, and the observation that the response to pressure was similar in monocytes from non-propofol-anesthetized patients and monocytes from healthy unanesthetized volunteers suggests that at least some other anesthetic agents might not exert a similar effect on pressure-stimulated phagocytosis. It remains conceivable that some intravenous anesthetic agent other than those administered to our non-propofol-anesthetized patients might also have a propofol-like effect on macrophage phagocytosis.
However, a comprehensive survey of anesthetic and sedating agents is beyond the scope of the present study.
Chen et al. (11) described inhibition of macrophage phagocytosis at 6 and 24 h after treatment with propofol. However, close scrutiny of their report also demonstrates increased phagocytic activity after a shorter 1-h treatment period, consistent with our present observation. Although monocytes migrate into surgical sites and differentiate into macrophages over time, tissue macrophages are resident within the surgical site at the time of surgery and begin to interact with contaminating bacteria or necrotic debris from the time of initial incision. We studied the effects of shorter-term propofol treatment, because we were interested in macrophage function in the midst of a typical surgical procedure, and the duration of most surgical procedures is less than the 6-to 24-h periods studied by some other groups. Whether pressure and propofol affect monocyte differentiation into a mature macrophage phenotype and whether longer propofol treatments more analogous to longterm sedation in the intensive care unit would exhibit similar effects await further exploration.
Phagocytosis in human macrophages is accompanied by changes in ion channel currents (24) , and Cl Ϫ channels are important for phagocytosis in neutrophil and microglia (15, 37) . Propofol, also known as a GABA A receptor agonist, binds to the ␤ 2 -subunit of the GABA A receptor (4), which regulates Cl Ϫ channels (32) . Our data suggest that propofol modulates macrophage phagocytosis via activation of GABA A receptors. Indeed, reversal of pressure-stimulated macrophage phagocytosis by propofol was prevented by GABA A receptor antagonists. However, these antagonists did not affect basal phagocytosis or stimulation of basal phagocytosis by propofol, suggesting that GABA A receptor activation might be involved in macrophage phagocytosis only when macrophages are exposed to propofol under conditions of increased extracellular pressure.
Consistent with our present observation that blocking the GABA A receptor prevents stimulation of macrophage phagocytosis by pressure, Gillette and Dacheux (19) also demonstrated that GABA A receptors are activated by pressure in rabbit retina. How macrophages or other cells initially sense extracellular pressure is not entirely clear. Extrapolation from work in other cell types suggests a series of possibilities that are not necessarily mutually exclusive. These might include the activation of pressure-sensitive ion channels (24), mechanotransduction by changes in the patterns of tension and compression in the cytoskeleton (9) , and activation of membraneassociated proteins, such as the heterotrimeric GTP-binding proteins (27) . Further investigation beyond the scope of the present study is required to delineate which, if any, of these cellular response elements might contribute to mechanosensing in macrophages.
We previously reported that p38 activation and/or inhibition of an FAK-ERK pathway and Akt through activation of p70S6k contribute to stimulation of phagocytosis by increased extracellular pressure in THP-1 macrophages and human peripheral monocytes (51) (52) (53) . Propofol has been shown to increase ERK phosphorylation and actin content in neurons (40) . We observed a similar increase in ERK phosphorylation in propofol-treated THP-1 macrophages. However, our previous study suggests that inhibition of ERK phosphorylation by pressure is accompanied by pressure-stimulated THP-1 macrophage phagocytosis (53) . Furthermore, ERK phosphorylation was decreased by exposure to pressure in propofol-treated cells as well as in untreated cells. Thus activation of ERK by propofol is not likely to mediate the propofol effect on monocyte/macrophage phagocytosis under ambient and increased pressure. Pretreatment with propofol also did not alter FAK, p38, or Akt phosphorylation in THP-1 macrophages, suggesting that propofol is likely to act independently of these signals.
The docking protein p130cas is an adaptor that promotes protein-protein interaction, facilitates focal adhesion complex formation along with FAK and Src, and mediates integrin signal transduction, leading to migration, proliferation, and survival of various cell types (17, 45, 48) . p130cas is required for Salmonella typhimurium invasion into host cells (49) , and the secreted virulent protein of Yersinia, YopH, binds to p130cas as a substrate (6) . Glucocorticoids enhance macrophage phagocytosis of apoptotic cells by downregulating p130cas expression (18) , which would be expected to also reduce phosphorylated p130cas. Consistent with this finding, the inhibition of p130cas phosphorylation by exposure to increased extracellular pressure or pretreatment with propofol was also associated with increased phagocytosis in human peripheral monocytes and THP-1 macrophages (Fig. 6A and  Fig. 3, A and B) , and inhibition of p130cas protein expression by p130cas-specific siRNA also increased basal phagocytosis in our studies (Fig. 6, B and C) . Although p130cas has been reported to play a role as a mechanotransducer for cell deformation (17, 46) , the role of p130cas in mechanical stimulationinduced phagocytosis in monocytes or macrophages has not Top: typical Western blot probed for phosphorylated p130cas and then stripped and reprobed for total p130cas as a loading control. Bottom: summary of densitometric results. Values are means Ϯ SE (n ϭ 10), expressed as ratio of phosphorylated p130cas to total p130cas, normalized to Intralipid-treated control values. p130cas phosphorylation was inhibited by pressure and picrotoxin. *P Ͻ 0.001 vs. nonpicrotoxin-treated control (Ϫ). Right: effect of picrotoxin on propofol-treated THP-1 macrophages. Values are means Ϯ SE (n ϭ 10). In propofoltreated THP-1 macrophages, pressure increased p130cas phosphorylation in non-picrotoxin-and picrotoxin-treated cells. Significantly different from corresponding control: *P Ͻ 0.05; # P Ͻ 0.005.
been examined. Here, we demonstrated that exposure to extracellular pressure or the anesthetic agent propofol inhibited p130cas phosphorylation, leading in each case to enhanced phagocytosis. We also observed reduced p130cas phosphorylation in THP-1 macrophages treated with the GABA A receptor antagonist picrotoxin, which did not affect basal macrophage phagocytosis. Propofol and picrotoxin bind to GABA A receptors. Picrotoxin reduces GABA A receptor currents (38) , whereas propofol increases GABA A receptor currents (16) . Activation of p130cas is also regulated in a system without ion channels (46) . Inhibition of p130cas phosphorylation might be associated with GABA A receptor gating, which may induce actin cytoskeletal reorganization. However, if GABA A receptor currents are reduced by picrotoxin, macrophage phagocytosis is unaffected by this agent, even though it also reduces p130cas phosphorylation. Ince et al. (24) reported that ionic current changes are involved in human macrophage phagocytosis. The direction of ionic current changes might be another important factor for macrophage phagocytosis. Our data also showed that exposure to pressure did not inhibit p130cas phosphorylation further in picrotoxin-treated cells, but pressure augmented p130cas phosphorylation in cells treated with propofol and cells treated with picrotoxin ϩ propofol. These results suggest that regulation of macrophage phagocytosis by pressure requires at least tonic levels of the GABA A receptor currents but is independently influenced by p130cas phosphorylation. Propofol appears to modulate the effect via its effect on p130cas phosphorylation.
In conclusion, the commonly used anesthetic agent propofol stimulates macrophage phagocytosis but reverses pressurestimulated macrophage phagocytosis through activation of GABA A receptors and inhibition of p130cas phosphorylation. Whether these effects are beneficial or detrimental likely depends on the clinical situation, inasmuch as inflammatory activity may help patients resolve disease states or cause further disease in pathological hyperinflammatory or septic conditions. However, these results demonstrate a mechanism for an immunomodulatory effect of propofol and suggest potential novel targets for interventions to modulate phagocytosis by mimicking the propofol pathway or by blocking it in propofol-treated patients.
